{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:54:30Z","timestamp":1780710870803,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T00:00:00Z","timestamp":1527984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1687-y","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T11:47:00Z","timestamp":1527248820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series"],"prefix":"10.1186","volume":"12","author":[{"given":"Rossella","family":"Talotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Batticciotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Ditto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,3]]},"reference":[{"issue":"6","key":"1687_CR1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/rheumatology\/ker455","volume":"51","author":"M Andres","year":"2012","unstructured":"Andres M, Vela P, Romera C. Marked improvement of lung rheumatoid nodules after treatment with tocilizumab. Rheumatology (Oxford). 2012;51(6):1132\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1687_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-4632.2011.04966.x","volume":"51","author":"HM Al Attia","year":"2012","unstructured":"Al Attia HM, Abushawish M. Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules. Int J Dermatol. 2012;51(2):197\u20138.","journal-title":"Int J Dermatol"},{"issue":"3","key":"1687_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.det.2015.03.004","volume":"33","author":"JS Tilstra","year":"2015","unstructured":"Tilstra JS, Rheumatoid Nodules LDW. Dermatol Clin. 2015;33(3):361\u201371.","journal-title":"Dermatol Clin"},{"issue":"11","key":"1687_CR4","first-page":"2313","volume":"29","author":"DL Mattey","year":"2002","unstructured":"Mattey DL, Dawes PT, Fisher J, Brownfield A, Thomson W, Hajeer AH, et al. Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1\/TNF gene interaction. J Rheumatol. 2002;29(11):2313\u20138.","journal-title":"J Rheumatol"},{"issue":"2","key":"1687_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/art.10776","volume":"48","author":"PA Hessian","year":"2003","unstructured":"Hessian PA, Highton J, Kean A, Sun CK, Chin M. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum. 2003;48(2):334\u20138.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1687_CR6","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.23455","volume":"58","author":"LK Stamp","year":"2008","unstructured":"Stamp LK, Easson A, Lehnigk U, Highton J, Hessian PA, Different T. cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. Arthritis Rheum. 2008;58(6):1601\u20138.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1687_CR7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","volume":"35","author":"A Peters","year":"2011","unstructured":"Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity. 2011;35(6):986\u201396.","journal-title":"Immunity"},{"issue":"3","key":"1687_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/cei.12017","volume":"171","author":"B Pesce","year":"2013","unstructured":"Pesce B, Soto L, Sabugo F, Wurmann P, Cuchacovich M, L\u00f2pez MN, Sotelo PH, . Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clin Exp Immunol. 2013;171(3):237\u201342.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1687_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/art.38246","volume":"66","author":"A Thiolat","year":"2014","unstructured":"Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, et al. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis. Arthritis Rheumatol. 2014;66(2):273\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1687_CR10","first-page":"77","volume":"32","author":"G Guggino","year":"2014","unstructured":"Guggino G, Giardina AR, Raimondo S, Giardina G, Sireci G, Dieli F, et al. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion. Clin Exp Rheumatol. 2014;32(1):77\u201381.","journal-title":"Clin Exp Rheumatol"},{"key":"1687_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1592\/phco.22.13.1157.33525","volume":"22","author":"E Patatanian","year":"2002","unstructured":"Patatanian E, Thompson DF. A review of methotrexate-induced accelerated nodulosis. Pharmacotherapy. 2002;22:1157\u201362.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"1687_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/01.rhu.0000147054.26777.43","volume":"10","author":"CL Mackley","year":"2004","unstructured":"Mackley CL, Ostrov BE, Ioffreda MD. Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis. J Clin Rheumatol. 2004;10(6):336\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"1687_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00393-004-0537-z","volume":"63","author":"MG Braun","year":"2004","unstructured":"Braun MG, Van Rhee R, Becker-Capeller D. Development and\/or increase of rheumatoid nodules in RA patients following leflunomide therapy. Z Rheumatol. 2004;63(1):84\u20137.","journal-title":"Z Rheumatol"},{"issue":"5","key":"1687_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3899\/jrheum.080648","volume":"36","author":"J Chao","year":"2009","unstructured":"Chao J, Parker BA, Zvaifler NJ. Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis. J Rheumatol. 2009;36(5):1087\u20138.","journal-title":"J Rheumatol"},{"issue":"8","key":"1687_CR15","first-page":"1664","volume":"34","author":"Y Berkun","year":"2007","unstructured":"Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, et al. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. J Rheumatol. 2007;34(8):1664\u20139.","journal-title":"J Rheumatol"},{"issue":"4","key":"1687_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00005792-200107000-00006","volume":"80","author":"SS Ahmed","year":"2001","unstructured":"Ahmed SS, Arnett FC, Smith CA, Ahn C, Reveille JD. The HLA- DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis. Medicine (Baltimore). 2001;80(4):271\u20138.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1687_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2340\/00015555-1866","volume":"95","author":"N Shimoura","year":"2015","unstructured":"Shimoura N, Fukunaga A, Nagai H, Oka M, Nishigori C. Epstein-Barr virus-associated methotrexate-induced accelerated rheumatoid nodulosis. Acta Derm Venereol. 2015;95(1):100\u20131.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1687_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/art.10535","volume":"47","author":"G Cunnane","year":"2002","unstructured":"Cunnane G, Warnock M, Fye KH, Daikh DI. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002;47(4):445\u20139.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1687_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/rheumatology\/keu008","volume":"53","author":"S Sakaue","year":"2014","unstructured":"Sakaue S, Sumitomo S, Kubo K, Fujio K, Yamamoto K. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis. Rheumatology (Oxford). 2014;53(8):1529\u201330.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1687_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jbspin.2014.06.006","volume":"82","author":"M Fechtenbaum","year":"2015","unstructured":"Fechtenbaum M, Banse C, Boyard-Lasselin P, Go\u00ebb V. Toxidermia under treatment with tocilizumab for rheumatoid arthritis. Joint Bone Spine. 2015;82(1):69\u201370.","journal-title":"Joint Bone Spine"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1687-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1687-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1687-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T23:07:12Z","timestamp":1559516832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1687-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1687-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,3]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consents is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"154"}}